The alcohol withdrawal syndrome, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.8, pp.854-862, 2008. ,
DOI : 10.1136/jnnp.2007.128322
Biochemical and Neurotransmitter Changes Implicated in Alcohol-Induced Brain Damage in Chronic or 'Binge Drinking' Alcohol Abuse, Alcohol and Alcoholism, vol.44, issue.2, pp.128-163, 2009. ,
DOI : 10.1093/alcalc/agn100
Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?, Experimental Neurology, vol.224, issue.1, pp.37-47, 2010. ,
DOI : 10.1016/j.expneurol.2010.03.021
Dual Effects of Anandamide on NMDA Receptor-Mediated Responses and Neurotransmission, Journal of Neurochemistry, vol.70, issue.2, pp.671-677, 1998. ,
DOI : 10.1046/j.1471-4159.1998.70020671.x
Characterization of the Neuroprotective Effect of the Cannabinoid Agonist WIN-55212 in an In Vitro Model of Hypoxic-Ischemic Brain Damage in Newborn Rats, Pediatric Research, vol.54, issue.2, pp.169-73, 2006. ,
DOI : 10.1203/01.pdr.0000228839.00122.6c
??9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity, Brain Research, vol.1128, pp.61-70, 2007. ,
DOI : 10.1016/j.brainres.2006.03.011
Cannabinoid receptors and their ligands, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.66, issue.2-3, pp.101-122, 2002. ,
DOI : 10.1054/plef.2001.0341
The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABAA receptors after chronic ethanol exposure, Journal of Neurochemistry, vol.52, issue.3, pp.741-52, 2007. ,
DOI : 10.1111/j.1471-4159.2007.04577.x
URL : https://hal.archives-ouvertes.fr/inserm-00746175
Cytotoxic effect of alcohol-withdrawal on primary cultures of cortical neurones, Drug and Alcohol Dependence, vol.61, issue.2, pp.155-62, 2001. ,
DOI : 10.1016/S0376-8716(00)00132-0
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides, Journal of Psychiatric Research, vol.44, issue.9, pp.591-598, 2010. ,
DOI : 10.1016/j.jpsychires.2009.11.013
Increased sensitivity to NMDA is involved in alcohol-withdrawal induced cytotoxicity observed in primary cultures of cortical neurones chronically pre-treated with ethanol, Neurochemistry International, vol.40, issue.7, pp.585-591, 2002. ,
DOI : 10.1016/S0197-0186(01)00131-0
The Neuropathology of Alcohol-Related Brain Damage, Alcohol and Alcoholism, vol.44, issue.2, pp.136-176, 2009. ,
DOI : 10.1093/alcalc/agn102
Alcohol and withdrawal: from animal research to clinical issues, Neuroscience & Biobehavioral Reviews, vol.27, issue.3, pp.189-197, 2003. ,
DOI : 10.1016/S0149-7634(03)00030-7
Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data, CNS & Neurological Disorders - Drug Targets, vol.9, issue.1, pp.55-64, 2010. ,
DOI : 10.2174/187152710790966623
The endocannabinoid system as a target for the treatment of motor dysfunction, British Journal of Pharmacology, vol.276, issue.1074, pp.1029-1069, 2009. ,
DOI : 10.1111/j.1476-5381.2008.00088.x
Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity, Mol Pharmacol, vol.54, pp.459-62, 1998. ,
Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores, Neuropharmacology, vol.48, issue.8, pp.1086-96, 2005. ,
DOI : 10.1016/j.neuropharm.2005.01.005
The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies, Central Nervous System Agents in Medicinal Chemistry, vol.10, issue.1, pp.47-64, 2010. ,
DOI : 10.2174/187152410790780145
Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation, Molecular and Cellular Neuroscience, vol.34, issue.4, pp.551-61, 2007. ,
DOI : 10.1016/j.mcn.2006.12.005
Chronic Ethanol Increases the Cannabinoid Receptor Agonist Anandamide and Its Precursor N-Arachidonoylphosphatidylethanolamine in SK - N - SH Cells, Journal of Neurochemistry, vol.19, issue.2, pp.522-530, 1999. ,
DOI : 10.1046/j.1471-4159.1999.0720522.x
Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.66, issue.2-3, pp.287-299, 2002. ,
DOI : 10.1054/plef.2001.0352
Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons, European Journal of Pharmacology, vol.466, issue.1-2, pp.73-83, 2003. ,
DOI : 10.1016/S0014-2999(03)01557-7
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine, Brain Research, vol.954, issue.1, pp.73-81, 2002. ,
DOI : 10.1016/S0006-8993(02)03344-9
Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse, British Journal of Pharmacology, vol.61, issue.4, pp.455-64, 2004. ,
DOI : 10.1038/sj.bjp.0705963
Excitotoxic cell death, Journal of Neurobiology, vol.68, issue.9, pp.1261-1276, 1992. ,
DOI : 10.1002/neu.480230915
Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-D-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons, Journal of Pharmacology and Experimental Therapeutics, vol.331, issue.3, pp.1062-70, 2009. ,
DOI : 10.1124/jpet.109.156216
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol, Neuroscience Letters, vol.421, issue.3, pp.270-274, 2007. ,
DOI : 10.1016/j.neulet.2007.05.052
Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats, Addiction Biology, vol.267, issue.1, 2011. ,
DOI : 10.1111/j.1369-1600.2010.00299.x
The Cannabinoid CB1 Receptor Antagonist, Rimonabant, as a Promising Pharmacotherapy for Alcohol Dependence: Preclinical Evidence, Molecular Neurobiology, vol.183, issue.Suppl, pp.102-114, 2007. ,
DOI : 10.1007/s12035-007-0017-y
Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence, Journal of Clinical Psychopharmacology, vol.28, issue.3, pp.317-341, 2008. ,
DOI : 10.1097/JCP.0b013e318172b8bc
Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers, Psychopharmacology, vol.33, issue.1, pp.37-44, 2010. ,
DOI : 10.1007/s00213-009-1704-3
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptormediated signaling, Nat Med, vol.7, pp.59-64, 2001. ,